August 14, 2025
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Controlling disease activity in systemic lupus erythematosus is one of many ways to prevent cardiovascular events in these patients, according to a presenter at the 2025 AWIR annual conference.“Organ damage occurs early and is associated with significant morbidity and mortality in SLE,” Maria Dall'Era, MD, chief of the University of California, San Francisco Division of Rheumatology
August 14, 2025
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Early hydroxychloroquine initiation among people with discoid lupus erythematosus — the most common subtype of cutaneous lupus —…

DESTIN, Fla. — New treatments have improved outcomes in lupus, but preventing disease in the early stages remains elusive,…

SLE patients with suboptimal drug exposure face increased heart risk

Novel therapies may allow more patients with lupus to reach remission or low disease activity, according to a presenter at the…

Patients with systemic lupus erythematosus who received autologous chimeric antigen receptor T-cell therapy enjoyed potent B-cell…

Helping patients with lupus navigate disability insurance, so they can maintain care after a job loss, is just one step…